Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127126671 | 12712667 | 1 | I | 201605 | 20160810 | 20160902 | 20160902 | EXP | CN-PFIZER INC-2016403560 | PFIZER | 56.00 | YR | F | Y | 55.00000 | KG | 20160902 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127126671 | 12712667 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY | Y | N11247 | 20702 | 10 | MG | FILM-COATED TABLET | QD | ||||
| 127126671 | 12712667 | 2 | SS | XUEZHIKANG | RED YEAST | 1 | Oral | 0.6 G, 2X/DAY | Y | 20151107 | 0 | .6 | G | CAPSULE | BID | ||||
| 127126671 | 12712667 | 3 | C | KELIN'AO | 2 | Intravenous drip | 320 MG, 1X/DAY | 15091414 | 0 | 320 | MG | INJECTION | QD | ||||||
| 127126671 | 12712667 | 4 | C | APROVEL | IRBESARTAN | 1 | Oral | 150 MG, 1X/DAY | 5A349 | 0 | 150 | MG | QD | ||||||
| 127126671 | 12712667 | 5 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 25 MG, 1X/DAY | 5A718 | 0 | 25 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127126671 | 12712667 | 1 | Hyperlipidaemia |
| 127126671 | 12712667 | 2 | Hyperlipidaemia |
| 127126671 | 12712667 | 4 | Essential hypertension |
| 127126671 | 12712667 | 5 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127126671 | 12712667 | HO |
| 127126671 | 12712667 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127126671 | 12712667 | Blood creatine phosphokinase MB increased | |
| 127126671 | 12712667 | Blood creatine phosphokinase increased | |
| 127126671 | 12712667 | Chest discomfort | |
| 127126671 | 12712667 | Dizziness | |
| 127126671 | 12712667 | Fatigue | |
| 127126671 | 12712667 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127126671 | 12712667 | 1 | 20120501 | 20160519 | 0 | |
| 127126671 | 12712667 | 2 | 20160519 | 20160523 | 0 | |
| 127126671 | 12712667 | 3 | 20160520 | 20160520 | 0 | |
| 127126671 | 12712667 | 4 | 20160520 | 20160530 | 0 | |
| 127126671 | 12712667 | 5 | 20160520 | 20160524 | 0 |